id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-E-1240-0008,FDA,FDA-2014-E-1240,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2019-07-09T04:00:00Z,2019,7,2019-07-09T04:00:00Z,,2019-07-09T15:28:45Z,,0,0,0900006483d6f1e6
FDA-2014-E-1240-0007,FDA,FDA-2014-E-1240,Determination of Regulatory Review Period for Purposes of Patent Extension: SEDASYS System,Notice,Determinations,2018-02-07T05:00:00Z,2018,2,2018-02-07T05:00:00Z,2018-04-10T03:59:59Z,2018-02-07T17:10:10Z,2018-02432,0,0,0900006482ef688d
FDA-2014-E-1240-0006,FDA,FDA-2014-E-1240,Letter from CDER to United States Patent and Trademark Office,Other,Letter(s),2017-05-15T04:00:00Z,2017,5,2017-05-15T04:00:00Z,,2017-05-15T13:29:45Z,,0,0,09000064825b90a5
FDA-2014-E-1240-0005,FDA,FDA-2014-E-1240,Letter from U.S. Patent and Trademark Office to FDA,Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T17:34:25Z,,0,0,0900006482434448
FDA-2014-E-1240-0004,FDA,FDA-2014-E-1240,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-11-04T05:00:00Z,2015,11,2015-11-04T05:00:00Z,,2015-11-04T14:14:22Z,,0,0,0900006481d0ca88
FDA-2014-E-1240-0003,FDA,FDA-2014-E-1240,Patent Extension Application from  Hogan Lovells US LLP (oh behalf of Scott Laboratories Inc.),Other,Application,2014-08-25T04:00:00Z,2014,8,2014-08-25T04:00:00Z,,2014-08-25T15:39:59Z,,0,0,090000648184287b
FDA-2014-E-1240-0001,FDA,FDA-2014-E-1240,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2014-08-25T04:00:00Z,2014,8,2014-08-25T04:00:00Z,,2015-01-28T13:40:32Z,,0,0,0900006481842873
FDA-2014-E-1240-0002,FDA,FDA-2014-E-1240,Patent Extension Application from  Hogan Lovells US LLP (oh behalf of Scott Laboratories Inc.) - WITHDRAWN,Other,,2014-08-25T00:00:00Z,2014,8,,,2014-08-25T15:40:29Z,,0,1,0900006481842876